Aeva Technologies, Inc. - Equity Warrant
US ˙ NasdaqGS ˙ US00835Q1114

Introduction

This page provides a comprehensive analysis of the known insider trading history of Peter Hebert. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Peter Hebert has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MTTR / Matterport, Inc. Director 0
US:AEVA / Aeva Technologies, Inc. 10% Owner 14,692,316
US:SNCE / Science 37 Holdings, Inc. 10% Owner 8,743,999
US:RXRX / Recursion Pharmaceuticals, Inc. 13,021,519
US:LTCH / Latch, Inc. 10% Owner 4,084,493
US:LUXA / Lux Health Tech Acquisition Corp - Class A 10% Owner 5,933,333
US:MRAM / Everspin Technologies, Inc. Director 29,131
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Peter Hebert. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases AEVAW / Aeva Technologies, Inc. - Equity Warrant - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in AEVAW / Aeva Technologies, Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AEVAW / Aeva Technologies, Inc. - Equity Warrant Insider Trades
Insider Sales AEVAW / Aeva Technologies, Inc. - Equity Warrant - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AEVAW / Aeva Technologies, Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

AEVAW / Aeva Technologies, Inc. - Equity Warrant Insider Trades
Insider Purchases MRAM / Everspin Technologies, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in AEVAW / Aeva Technologies, Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2016-10-13 MRAM Hebert Peter 137,420 8.0000 137,420 8.0000 1,099,360 277 24.88 2,319,650 211.00

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MRAM / Everspin Technologies, Inc. Insider Trades
Insider Sales MRAM / Everspin Technologies, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AEVAW / Aeva Technologies, Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MRAM / Everspin Technologies, Inc. Insider Trades
Insider Purchases RXRX / Recursion Pharmaceuticals, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in AEVAW / Aeva Technologies, Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

RXRX / Recursion Pharmaceuticals, Inc. Insider Trades
Insider Sales RXRX / Recursion Pharmaceuticals, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AEVAW / Aeva Technologies, Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

RXRX / Recursion Pharmaceuticals, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Peter Hebert as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-03-03 2025-02-28 4 MTTR Matterport, Inc./DE
Class A Common Stock
D - Sale to Issuer -279,793 0 -100.00
2023-08-18 2023-08-16 4 MTTR Matterport, Inc./DE
Class A Common Stock
P - Purchase 50,000 279,793 21.76 2.50 124,995 699,455
2023-06-14 2023-06-13 4 MTTR Matterport, Inc./DE
Class A Common Stock
M - Exercise 38,126 267,919 16.59
2022-08-09 2022-08-05 4 AEVA Aeva Technologies, Inc.
Common Stock
J - Other -7,346,159 14,692,316 -33.33
2022-04-06 2022-04-04 4 SNCE Science 37 Holdings, Inc.
Common Stock
J - Other -2,914,667 8,743,999 -25.00
2022-02-28 2022-02-24 4 MTTR Matterport, Inc./DE
Class A Common Stock
P - Purchase 20,000 229,793 9.53 6.38 127,500 1,464,930
2022-01-21 2022-01-18 4 MTTR Matterport, Inc./DE
Class A Common Stock
J - Other -6,306,411 18,919,230 -25.00
2022-01-21 2022-01-18 4 MTTR Matterport, Inc./DE
Class A common stock, par value $0.0001
J - Other 209,793 209,793
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A common stock
J - Other -4,265,576 13,021,519 -24.67
2021-10-18 3 SNCE Science 37 Holdings, Inc.
Common Stock
11,658,666
2021-10-18 3 SNCE Science 37 Holdings, Inc.
Common Stock
3,505,890
2021-10-05 2021-09-28 4 LTCH Latch, Inc.
Common Stock
J - Other -1,358,164 4,084,493 -24.95
2021-10-05 2021-09-28 4 LTCH Latch, Inc.
Common Stock
J - Other -2,409,489 7,228,469 -25.00
2021-09-10 2021-09-08 4 AEVA Aeva Technologies, Inc.
Common Stock
J - Other -7,346,159 22,038,475 -25.00
2021-08-10 3/A MTTR Matterport, Inc./DE
Class A Common Stock
25,225,654
2021-07-26 3 MTTR Gores Holdings VI, Inc.
Class A Common Stock
25,125,654
2021-06-08 3 LTCH Latch, Inc.
Common Stock
9,637,958
2021-06-08 3 LTCH Latch, Inc.
Common Stock
5,442,657
2021-03-19 3 AEVA Aeva Technologies, Inc.
Class A Common Stock
29,384,634
2021-03-19 3 AEVA Aeva Technologies, Inc.
Class A Common Stock
1,959,371
2020-11-02 2020-10-29 4 LUXA Lux Health Tech Acquisition Corp.
Warrants
P - Purchase 5,933,333 5,933,333 1.50 8,900,000 8,900,000
2020-05-20 2020-05-19 4 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
A - Award 20,131 29,131 223.68
2019-05-22 2019-05-21 4 MRAM EVERSPIN TECHNOLOGIES INC
Nonqualified Stock Option (Right to Buy)
A - Award 12,000 12,000
2019-05-22 2019-05-21 4 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
A - Award 6,000 9,000 200.00
2018-05-22 2018-05-21 4 MRAM EVERSPIN TECHNOLOGIES INC
Nonqualified Stock Option (Right to Buy)
A - Award 12,000 12,000
2018-05-22 2018-05-21 4 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
A - Award 3,000 3,000
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
Series A Preferred Stock
C - Conversion -219,916 0 -100.00
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
5% Convertible Subordinated Promissory Note
C - Conversion 0
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
5% Convertible Subordinated Promissory Note
C - Conversion 0
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
Series B Preferred Stock
C - Conversion -118,606 0 -100.00
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
P - Purchase 137,420 1,015,550 15.65 8.00 1,099,360 8,124,400
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
C - Conversion 89,946 878,130 11.41 6.40 575,654 5,620,032
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
C - Conversion 131,719 788,184 20.06 6.40 843,002 5,044,378
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
C - Conversion 118,606 656,465 22.05
2016-10-17 2016-10-13 4 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
C - Conversion 219,916 537,859 69.17
2016-10-07 3 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
635,886
2016-10-07 3 MRAM EVERSPIN TECHNOLOGIES INC
Common Stock
635,886
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)